Novo Nordisk has ended its partnership with Hims & Hers Health Inc., citing “deceptive marketing” and the selling of ...

Harbour BioMed has partnered with Otsuka Pharmaceutical Co., Ltd. to advance BCMAxCD3 bispecific T-cell engagers for the ...

Cellular Origins has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform ...

Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK. The opening ceremony was ...

PharmaLogic Holdings Corp., a CDMO, has completed its previously announced acquisition of a majority stake in Agilera Pharma.

Formation Bio’s subsidiary, Libertas Bio, has licensed gusacitinib, an oral dual JAK/SYK inhibitor, to Sanofi.

Aversa Fentanyl combines Nutriband’s Aversa abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch.

Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...

Will support spray drying and unit operations including granulation, encapsulation, compression and coating for oral dosage ...

This will support the advancement of a novel ophthalmic therapeutic through clinical development and onto the market.

How can early decisions in cell and gene therapy clinical development impact downstream progress toward commercialization and ...

They aim to transform output and labor requirements for CGT manufacturing using automated robotics manufacturing capabilities ...